According to Immunocore's latest financial reports the company's current EPS (TTM) is -$1.31. In 2022 the company made an earnings per share (EPS) of -$1.17 an increase over its 2021 EPS that were of -$4.22.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.31 | 12.31% |
2022 | -$1.17 | -72.4% |
2021 | -$4.22 | 164.68% |
2020 | -$1.59 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | 66.58% | ๐บ๐ธ USA |